About Samsung Biologics America

Samsung Biologics America (SBA) is our U.S. subsidiary committed to providing trusted services to our clients and industry partners. As part of our expansion efforts, we have established a San Francisco office to support our CDO services and a New Jersey office to enable close communication with current and potential clients worldwide.

SBA San Francisco
600 Gateway Blvd.,
South San Francisco, CA 94080, USA
SBA New Jersey
100 Challenger Rd,
Ridgefield Park, NJ 07660, USA
SBA Boston
260 Franklin St.,
Boston, MA 02110, USA
Directions to Samsung Biologics America image
San Francisco
New Jersey
Boston
Directions to Samsung Biologics America image
San Francisco
New Jersey
Boston
zoom in

Related Content

Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025 Image
Press Releases

Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025

June 6, 2023
INCHEON, S. KOREA, June 6, 2023 – While attending the 2023 BIO International Convention, Samsung Biologics (KRX:207940.KS), a leading contract development and manufacturing organization (CDMO), revealed details of the company’s future expansion plan to have its new fifth plant operational by April 2025. Recently on June 1, the company fully completed its latest and the world’s largest biomanufacturing plant, Plant 4. The move reinforces Samsung Biologics’ unmatched speed and commitment to providing partners with high-quality services and products in response to the surging demand for biologics.
From DCAT Week 2023: Samsung Biologics Investing $1.5 Bn for New Biomanufacturing Facility Image
Media Focus

From DCAT Week 2023: Samsung Biologics Investing $1.5 Bn for New Biomanufacturing Facility

April 4, 2023
Samsung Biologics, a CDMO of biologics, is investing KRW 1.9 trillion ($1.46 billion) for a new biomanufacturing facility in South Korea, which will be the first plant of the company’s second Bio Campus and its fifth biomanufacturing plant overall. Kevin Sharp, Vice President and Head of Samsung Biologics America–Sales, outlined the expansion at the DCAT Member Company Announcement Forum held on March 20, 2023, at DCAT Week.
Samsung Biologics holds opening ceremony for its New Jersey site Image
News Brief

Samsung Biologics holds opening ceremony for its New Jersey site

March 20, 2023
On March 19th, Samsung Biologics held the official opening ceremony for its regional office in Ridgefield Park, New Jersey, which will provide streamlined communication and support to clients based in the U.S. and Europe. CEO John Rim and other Samsung leaders were in attendance for the ribbon-cutting, reaffirming the company’s commitment to delivering world-class services to current and potential clients worldwide.
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion Image
Press Releases

Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion

March 17, 2023
​Incheon, S. Korea, March 17, 2023 – Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today that the company will commence the construction of a fifth plant as part of its strategic expansion in response to increased market demand.
Samsung Biologics to attend DCAT Week, expand U.S. presence with New Jersey site Image
News Brief

Samsung Biologics to attend DCAT Week, expand U.S. presence with New Jersey site

March 16, 2023
Samsung Biologics is participating in DCAT Week 2023 from March 20 to 23. Kevin Sharp, VP and Head of Samsung Biologics America Sales, will talk about the company’s manufacturing capacity expansion plans in a speaking session during the Member Company Announcement Forum at the event.
#CPHI22: As Samsung’s new plant comes online, it looks to expand in Korea and beyond Image
Media Focus

#CPHI22: As Samsung’s new plant comes online, it looks to expand in Korea and beyond

November 1, 2022
It is no secret that the CDMO arm of one of South Korea’s largest conglomerates has been expanding in 2022. In the middle of the year, Samsung Biologics was going to see a bump in funding from the Samsung group and now has committed to boosting its presence in South Korea and beyond.
Samsung Biologics unlocks additional capacity for production at its newest Plant 4 Image
Press Releases

Samsung Biologics unlocks additional capacity for production at its newest Plant 4

October 11, 2022
Incheon, S. Korea, October 11, 2022 – Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today that its Plant 4 – the world’s largest single bio manufacturing plant – has commenced GMP operations this month.
Samsung Biologics to purchase land for its second Bio Campus Image
Press Releases

Samsung Biologics to purchase land for its second Bio Campus

July 19, 2022
Incheon, S. Korea, July 18 2022 – Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), announced that it has signed a land purchase agreement with the Incheon Free Economic Zone(IFEZ) on July 18th to support the build out of its second Bio Campus.

SITE MAP

close
Close

Your download is ready

Click Download.

Download
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

COOKIE POLICY

Get focus link
Last Updated: [31 Mar 2023]

This Cookie Policy applies to the Samsung Biologics website (the “Website”). Please read this Cookie Policy carefully and feel free to contact us if you have any questions.

Your Privacy
- What are cookies?

A cookie is a small text file that a website saves on your computer or mobile device when you visit the Website. It enables the Website to remember your actions and preferences (such as language preferences) over a period of time, so you don't have to keep re-entering them whenever you come back to the Website or browse from one page to another.

- How to control cookies

You can control and/or delete cookies as you wish - for details, see http://www.aboutcookies.org. You can delete all cookies that are already on your computer and you can set most browsers to prevent them from being placed. If you do this, however, you may have to manually adjust some preferences every time you visit a site and some services and functionalities may not work.

Strictly Necessary
Cookies
Always Active

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance
Cookies

These cookies are used to collect information about how visitors use our website. We use the information to compile reports and to help us improve the website. The cookies collect information in an anonymous form, including the number of visitors to the website, where visitors have come to the website from and the pages they visited.

Google Analytics

This website uses Google Analytics, a website analytics service provided by Google, Inc. (“Google”). Google Analytics uses cookies and the information generated by the cookie is usually transmitted to a Google server in the USA and stored there.

You can prevent Google’s collection of the data generated by the cookie and related use of the website, including your IP address, as well as the processing of such data by Google by downloading and installing the browser plug-in available under the following link: http://tolls.google.com/dlpage/gaoptout.

Targeting
Cookies

These Cookies are used by advertising companies to inform and serve personalized ads more relevant to your interests. These Cookies also may facilitate sharing information with social networks or recording your interactions with particular ads.

We currently do not use any cookies in this category

close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION
E-mail sbl.infosec@samsung.com
닫기
With our R&D Center at the heart of the San Francisco biocluster, Samsung Biologics America provides cell line development services for your IND filing with a faster timeline and high quality to ensure successful commercialization throughout the entire process.